Primeri uporabe Must not be used in patients v Angleški in njihovi prevodi v Slovenski
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Official/political
-
Programming
MabCampath must not be used in patients:.
Multaq must not be used in patients who have severe problems with their liver or kidneys.
Rasilamlo in combination with an ACE inhibitor or an ARB must not be used in patients with diabetes, or moderate or severe kidney impairment.
Ocaliva must not be used in patients whose bile ducts are completely blocked.
Osigraft must not be used in patients who:.
Ljudje tudi prevajajo
It must not be used in patients who are bleeding or in patients who have a liver disease or a condition that is associated with an increased risk of bleeding.
Trabectedin must not be used in patients with CPKgt; 2.5 ULN(see section 4.2).
Ketek must not be used in patients with previous history of hepatitis and/ or jaundice associated with the use of telithromycin.
Docetaxel Zentiva must not be used in patients who have a neutrophil count of less than 1,500.
Kineret must not be used in patients with severe renal impairment(CLcr< 30 ml/minute)(see section 4.2).
Zevalin must not be used in patients who are pregnant or breast feeding.
Prasugrel must not be used in patients with severe hepatic impairment see section 4.
Revestive must not be used in patients who have, or are suspected to have, a cancer.
Riluzole Zentiva must not be used in patients who have liver disease or who have abnormally high levels of liver enzymes.
Extavia must not be used in patients who have decompensated liver disease(when the liver does not function normally).
Competact must not be used in patients who have heart failure, or problems with their liver or their kidneys.
Faslodex must not be used in patients who are pregnant or breast-feeding, or in patients who have severe liver disease.
Xeristar must not be used in patients with severe renal impairment(creatinine clearance< 30 ml/min; see section 4.3).
Tandemact must not be used in patients who have heart failure, problems with their liver or severe problems with their kidneys.
The tablets must not be used in patients who have abnormalities of the oesophagus or who cannot stand or sit up for at least an hour.
Competact must not be used in patients who have a disease that causes lack of oxygen to the tissues such as a recent heart attack or shock.
Abraxane must not be used in patients who are breast-feeding or who have low levels of neutrophils in the blood before starting treatment.
It must not be used in patients with hypernatraemia(increased sodium levels in the blood) and in pregnant and breastfeeding women.
It must not be used in patients who have severe liver disease or a disease that may cause bleeding such as a stomach ulcer or bleeding in the brain.
Halimatoz must not be used in patients with active tuberculosis or other severe infections, or in patients with moderate to severe heart failure(an inability of the heart to pump enough blood around the body).